These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30167098)

  • 1. Association between Sun Exposure, Vitamin D Intake, Serum Vitamin D Level, and Immunoglobulin G Level in Patients with Neuromyelitis Optica Spectrum Disorder.
    Shaygannejad V; Maljaei MB; Bank SS; Mirmosayyeb O; Maracy MR; Askari G
    Int J Prev Med; 2018; 9():68. PubMed ID: 30167098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between dietary total antioxidant capacity and NMO-IgG seropositivity in patients with neuromyelitis optica spectrum disorder.
    Rezaeimanesh N; Jahromi SR; Sahraian MA; Rafiee P; Moghadasi AN
    Clin Neurol Neurosurg; 2021 Oct; 209():106903. PubMed ID: 34461362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder.
    Eskandarieh S; Moghadasi AN; Sahraiain MA; Azimi AR; Molazadeh N
    Iran J Neurol; 2019 Jul; 18(3):93-98. PubMed ID: 31749929
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
    Wu Y; Zhong L; Geng J
    Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the 2015 neuromyelitis optica spectrum disorders diagnostic criteria in a cohort of Chinese patients.
    He M; Wu L; Huang D; Yu S
    Mult Scler Relat Disord; 2020 Nov; 46():102459. PubMed ID: 32853894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.
    Min JH; Waters P; Vincent A; Cho HJ; Joo BE; Woo SY; Lee SY; Shin HY; Lee KH; Kim BJ
    PLoS One; 2014; 9(9):e107274. PubMed ID: 25211011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
    Dale GH; Svendsen KB; Gjelstrup MC; Christensen T; Houen G; Nielsen E; Bek T; Petersen T
    Acta Neurol Scand; 2018 Jun; 137(6):582-588. PubMed ID: 29359475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual impairment in neuromyelitis optica spectrum disorders (NMOSD).
    Wu Y; Zhong L; Geng J
    J Chem Neuroanat; 2019 Apr; 97():66-70. PubMed ID: 30716473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
    Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
    Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK/STAT3 signaling pathway.
    Du L; Chang H; Xu W; Wei Y; Wang Y; Yin L; Zhang X
    Life Sci; 2020 Oct; 258():118217. PubMed ID: 32768575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.
    Cobo-Calvo A; Ruiz A; Richard C; Blondel S; Cavagna S; Strazielle N; Ghersi-Egea JF; Giraudon P; Marignier R
    PLoS One; 2020; 15(9):e0238301. PubMed ID: 32881954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.
    Hamid SH; Elsone L; Mutch K; Solomon T; Jacob A
    Mult Scler; 2017 Feb; 23(2):228-233. PubMed ID: 27553618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders.
    Gao M; Yao X; Ding J; Hong R; Wu Y; Huang H; Zhuang L; Li Z; Wang Y; Zhang Y; Guan Y
    J Clin Neurosci; 2019 Mar; 61():22-27. PubMed ID: 30692037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D
    Cho EB; Shin JH; Kwon S; Kim J; Seok JM; Kim BJ; Min JH
    Front Immunol; 2021; 12():677041. PubMed ID: 34394078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The progress of research on the immune pathogenesis and biomarkers in optic neuritis related to neuromyelitis optica].
    Liu WD; Yu MY; Jiang LB
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):228-233. PubMed ID: 30841690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
    Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
    J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
    Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
    J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.